AnalystsStephen WilleyStephen Willey's Stock Forecasts
AnalystsStephen Willey
Sectors:
Industries:
Analyst Ranking
Bottom 4%
#4390 out of 4565 analysts
Average Return
-11.72%
Win Rate
32%22 out of 69
Risk vs Reward
Poor
Good
Stephen Willey's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Inovio Pharmaceuticals IncINO | +118.20% | $164.88 | $359.76 | 2020-04-29 - 2020-06-26 | Strong Buy |
Xenon Pharmaceuticals IncXENE | +113.72% | $4.30 | $9.19 | 2018-03-08 - 2019-03-08 | Strong Buy |
Spark Therapeutics IncONCE | +96.53% | $57.70 | $113.40 | 2018-08-08 - 2019-02-27 | Strong Buy |
Loxo Oncology IncLOXO | +83.21% | $128.08 | $234.66 | 2018-05-09 - 2019-02-15 | Strong Buy |
Igm Biosciences IncIGMS | +58.06% | $4.84 | $7.65 | 2023-11-14 - 2024-04-25 | Strong Buy |
Stephen Willey Analyst Color
Get additional color on Stephen Willey's coverage of popular stocks
Stephen Willey's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Mei Pharma IncMEIP | 9 | Hold | $7.00 | +125.81% | Maintains | 14 days ago |
Cue Biopharma IncCUE | 5 | Strong Buy | $8.00 | +467.38% | Maintains | 18 days ago |
Vor Biopharma IncVOR | 4 | Strong Buy | $12.00 | +605.88% | Maintains | a month ago |
Incyte CorpINCY | 4 | Hold | $68.00 | +32.86% | Reiterates | a month ago |
Macrogenics IncMGNX | 1 | Strong Buy | $29.00 | +101.81% | Maintains | 2 months ago |
Abcellera Biologics IncABCL | 3 | Strong Buy | $17.00 | +368.32% | Maintains | 2 months ago |
Exelixis IncEXEL | 8 | Hold | $25.00 | +6.25% | Maintains | 3 months ago |
Compugen LtdCGEN | 1 | Strong Buy | $4.00 | +110.53% | Maintains | 4 months ago |
Xenon Pharmaceuticals IncXENE | 4 | Strong Buy | $62.00 | +54.61% | Maintains | 4 months ago |
Igm Biosciences IncIGMS | 2 | Strong Buy | $25.00 | +226.80% | Maintains | 5 months ago |
Hillevax IncHLVX | 2 | Strong Buy | $30.00 | +149.58% | Maintains | 6 months ago |
Atreca IncBCEL | 3 | Hold | $1.00 | +566.67% | Downgrades | 9 months ago |
X4 Pharmaceuticals IncXFOR | 1 | Strong Buy | $5.00 | +342.48% | Maintains | a year ago |
Nkarta IncNKTX | 2 | Strong Buy | $18.00 | +163.93% | Maintains | a year ago |
Zymeworks IncZYME | 3 | Strong Buy | $19.00 | +134.28% | Maintains | a year ago |
Nurix Therapeutics IncNRIX | 2 | Strong Buy | $31.00 | N/A | Maintains | a year ago |
Compass Therapeutics IncCMPX | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | a year ago |
Imago Biosciences IncIMGO | 2 | Hold | $36.00 | N/A | Downgrades | a year ago |
Omniab IncOABI | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | a year ago |
Aveo Pharmaceuticals IncAVEO | 1 | Hold | $15.00 | N/A | Downgrades | a year ago |
Ars Pharmaceuticals IncSPRY | 1 | Hold | $6.00 | N/A | Downgrades | 2 years ago |
Invivyd IncIVVD | 2 | Hold | $9.00 | N/A | Downgrades | 2 years ago |
Bolt Biotherapeutics IncBOLT | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 3 years ago |
Geron CorpGERN | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Inovio Pharmaceuticals IncINO | 4 | Hold | $288.00 | N/A | Downgrades | 4 years ago |
Seagen IncSGEN | 1 | Hold | $120.00 | N/A | Maintains | 4 years ago |
Molecular Templates IncMTEM | 1 | Strong Buy | $285.00 | N/A | Initiates Coverage On | 4 years ago |
Spark Therapeutics IncONCE | 3 | Hold | $114.50 | N/A | Downgrades | 5 years ago |
Alexion Pharmaceuticals IncALXN | 4 | Hold | $136.00 | N/A | Maintains | 6 years ago |
Alnylam Pharmaceuticals IncALNY | 3 | Strong Buy | $123.00 | N/A | Maintains | 6 years ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Strong Buy | $20.00 | N/A | Maintains | 6 years ago |
Ionis Pharmaceuticals IncIONS | 2 | Hold | $47.00 | N/A | Maintains | 6 years ago |
Biomarin Pharmaceutical IncBMRN | 3 | Strong Buy | $109.00 | N/A | Maintains | 6 years ago |
Lexicon Pharmaceuticals IncLXRX | 5 | Strong Buy | $23.00 | N/A | Maintains | 6 years ago |
Loxo Oncology IncLOXO | 3 | Strong Buy | $225.00 | N/A | Maintains | 6 years ago |
Innoviva IncINVA | 1 | Hold | $16.00 | N/A | Maintains | 6 years ago |
Akcea Therapeutics IncAKCA | 1 | Strong Buy | $30.00 | N/A | Maintains | 6 years ago |
Glycomimetics IncGLYC | 1 | Strong Buy | $25.00 | N/A | Maintains | 6 years ago |
Array Technologies IncARRY | 1 | Strong Buy | $23.00 | N/A | Maintains | 6 years ago |
Spero Therapeutics IncSPRO | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 6 years ago |
Keryx Biopharmaceuticals IncKERX | 1 | Hold | $5.00 | N/A | Maintains | 6 years ago |
Genocea Biosciences IncGNCAQ | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Tetraphase Pharmaceuticals IncTTPH | 1 | Strong Buy | N/A | N/A | Upgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.